scholarly article | Q13442814 |
P356 | DOI | 10.2337/DIAB.36.11.1341 |
P698 | PubMed publication ID | 3311856 |
P50 | author | Ralph A. DeFronzo | Q58689309 |
Eleuterio Ferrannini | Q59193801 | ||
P2093 | author name string | Felber JP | |
Golay A | |||
Meyer HU | |||
Jequier E | |||
Curchod B | |||
Maeder E | |||
Theibaud D | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
preproinsulin | Q7240673 | ||
insulin resistance | Q1053470 | ||
type 2 diabetes | Q3025883 | ||
P1104 | number of pages | 10 | |
P304 | page(s) | 1341-1350 | |
P577 | publication date | 1987-11-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. | |
P478 | volume | 36 |
Q36720516 | "Deficiency" of mitochondria in muscle does not cause insulin resistance |
Q36079707 | A case of congenital generalized lipodystrophy: metabolic effects of four dietary regimens. Lack of association of CGL with polymorphism in the lamin A/C Gene |
Q42501254 | Acute hyperinsulinemia inhibits intramyocellular triglyceride synthesis in high-fat-fed obese rats |
Q41429504 | Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. |
Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
Q51611865 | Benfluorex and blood glucose control in non insulin-dependent diabetic patients. |
Q51551827 | Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes. |
Q54347651 | Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy. |
Q51185707 | Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects. |
Q27302902 | Coordination between Drosophila Arc1 and a specific population of brain neurons regulates organismal fat |
Q46701744 | Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? |
Q34253010 | Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance |
Q41019246 | Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus |
Q46024732 | Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. |
Q37226887 | Determination of Plasma-Free Fatty Acid Kinetics with Tracers: Methodologic Considerations |
Q35335113 | Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA. |
Q37629051 | Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat. |
Q60572729 | Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance |
Q54252276 | Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension. |
Q51604953 | Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. |
Q71882554 | Effect of lipid oxidation on the regulation of glucose utilization in obese patients |
Q44057158 | Effect of long-term strength training on glucose metabolism. Implications for individual impact of high lean mass and high fat mass on relationship between BMI and insulin sensitivity |
Q71293202 | Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients |
Q43963805 | Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion |
Q38927658 | Eight weeks of overfeeding alters substrate partitioning without affecting metabolic flexibility in men. |
Q73228465 | Evidence for insulin resistance in black women from South Africa |
Q37586770 | Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways |
Q35096834 | Fasting hyperglycemia predicts lower rates of weight gain by increased energy expenditure and fat oxidation rate |
Q79088026 | Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss |
Q44058334 | Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans |
Q44896352 | Future targets in the treatment of type 2 diabetes |
Q39776666 | Gender difference in type 2 diabetes and the role of body iron stores. |
Q40553849 | Genetic epidemiology of non-insulin-dependent diabetes. |
Q34577169 | Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance |
Q41992364 | Glucose utilization by skeletal muscles in vivo in experimental hyperthyroidism in the rat. |
Q72795603 | How to measure insulin action in vivo |
Q40347651 | Human growth hormone prevents the protein catabolic side effects of prednisone in humans |
Q44846044 | Impaired Glucose Tolerance in Obesity is Associated with Insensitivity to Insulin in Multiple Aspects of Metabolism as Assessed by a Low Dose Incremental Insulin Infusion Technique |
Q46726621 | Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss |
Q89272930 | Inactivation of MAPK in epididymal fat and amelioration of triglyceride secretion by injection of GRK2 siRNA in ob/ob mice |
Q42013761 | Inactivation of pyruvate dehydrogenase complex in heart muscle mitochondria of gold-thioglucose-induced obese mice is not due to a stable increase in activity of pyruvate dehydrogenase kinase |
Q51588082 | Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. |
Q34225463 | Insulin resistance associated with lower rates of weight gain in Pima Indians |
Q41166028 | Insulin resistance in non-insulin-dependent diabetes mellitus. A review |
Q38679694 | Insulin resistance in skeletal muscles of patients with diabetes mellitus |
Q44802852 | Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA. |
Q34110324 | Interaction between glucose and free fatty acid metabolism in human skeletal muscle |
Q34460929 | Intra-individual variability of CO₂ breath isotope enrichment compared to blood glucose in the oral glucose tolerance test |
Q34243161 | Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake |
Q36632211 | Intramuscular lipid oxidation and obesity |
Q35818094 | Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism |
Q46654997 | Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes |
Q45091537 | Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II. |
Q40814275 | Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus |
Q44255049 | Metabolic response to a mixed meal in obese and lean women from two South african populations. |
Q33786866 | Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications |
Q37408155 | Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance |
Q39501571 | Mitochondrial function assessed by 31P MRS and BOLD MRI in non-obese type 2 diabetic rats |
Q80362514 | Molecular mechanisms of diabetes reversibility after bariatric surgery |
Q41159921 | Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus |
Q51596796 | Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man. |
Q37105184 | Novel noninvasive breath test method for screening individuals at risk for diabetes. |
Q46499119 | Obesity rather than regional fat depots marks the metabolomic pattern of adipose tissue: an untargeted metabolomic approach |
Q39991764 | Oxidation of Intracellular and Extracellular Fatty Acids in Skeletal Muscle: Application of kinetic modeling, stable isotopes and liquid chromatography/electrospray ionization ion-trap tandem mass spectrometry technology |
Q35787142 | Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview |
Q40743226 | Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment |
Q35093473 | Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study |
Q34294651 | Plasma ferritin and type 2 diabetes mellitus: a critical review |
Q58763746 | Prolonged fasting-induced metabolic signatures in human skeletal muscle of lean and obese men |
Q54299084 | Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. |
Q40129986 | Regulation of FAT/CD36 mRNA gene expression by long chain fatty acids in the differentiated 3T3-L1 cells |
Q34175102 | Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. |
Q37366568 | Role of the glucosamine pathway in fat-induced insulin resistance |
Q41731797 | Serum ferritin and glucose homeostasis: change in the association by glycaemic state. |
Q51595929 | Seven consecutive days of exercise lowers plasma insulin responses to an oral glucose challenge in sedentary elderly. |
Q44355154 | Skeletal muscle lipid metabolism with obesity |
Q77378552 | Skeletal muscle low attenuation area and maximal fat oxidation rate during submaximal exercise in male obese individuals |
Q35087568 | Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? |
Q34211446 | Skeletal muscle utilization of free fatty acids in women with visceral obesity |
Q57580397 | Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery |
Q39484595 | Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study |
Q51611436 | The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non-insulin-dependent) Diabetic Patients |
Q79769244 | The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats |
Q41391462 | The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis |
Q42019713 | Tissue differences in the response of the pyruvate dehydrogenase complex to a glucose load during the development of obesity in gold-thioglucose-obese mice |
Q33839929 | Training status diverges muscle diacylglycerol accumulation during free fatty acid elevation |
Search more.